concert
effort
world
health
organis
sinc
poliomyel
threshold
global
erad
wild
polioviru
type
wpv
erad
wpv
wpv
still
present
pakistan
afghanistan
live
attenu
oral
polio
vaccin
opv
mainstay
provid
durabl
humor
intestin
immun
easi
administ
low
cost
howev
opv
two
major
risk
due
genet
instabl
first
may
rare
caus
sporad
case
vaccineassoci
paralyt
poliomyel
vapp
given
vaccin
dose
may
revert
neurovirul
caus
paralysi
vaccin
recipi
nonimmun
contact
otherwis
immunolog
compet
vapp
may
also
occur
person
primari
immunodefici
antibodi
product
second
risk
emerg
genet
diverg
neurovirul
vaccinederiv
poliovirus
vdpv
resembl
wpv
caus
outbreak
area
low
opv
coverag
wherea
vapp
advers
event
follow
dose
opv
vdpv
poliovirus
whose
genet
properti
show
prolong
replic
transmiss
three
differ
type
vdpv
report
circul
vdpv
cvdpv
outbreak
low
opv
coverag
set
cvdpv
seen
worldwid
identifi
regist
geneva
among
cvdpv
case
report
sinc
associ
cvdpv
updat
vaccinederiv
poliovirus
worldwid
januari
publish
recent
four
avdpv
isol
afp
patient
four
differ
state
india
period
addit
two
vdpv
isol
escap
detect
screen
assay
global
polio
laboratori
network
report
mumbai
india
first
seen
girl
afp
januari
identifi
sabin
type
second
type
vdpv
found
immunocompet
girl
year
old
march
new
confirm
case
vdpv
child
report
delhi
novemb
identifi
p
replac
trival
opv
bival
opv
greatli
elimin
risk
circul
vdpv
case
ivdpv
infect
mainten
high
level
immun
comprehens
ipv
coverag
necessari
protect
ivdpv
spread
detect
chronic
ivdpv
exeretor
suitabl
antivir
therapi
also
import
infect
p
vivax
p
falciparum
occur
approxim
equal
frequenc
state
india
malaria
endem
three
speci
p
malaria
p
oval
p
knowlesi
report
less
often
mix
infect
report
peru
brazil
ethiopia
papua
new
guinea
malaria
diagnosi
india
base
primarili
microscopi
peripher
blood
smear
rapid
diagnost
test
differenti
monoinfect
mix
infect
total
blood
sampl
posit
p
falciparum
microscopi
subject
speciesspecif
nest
pcr
target
rrna
gene
posit
mix
infect
mix
infect
p
vivax
p
falciparum
seen
p
falciparum
malaria
p
falciparum
p
oval
p
falciparum
p
malaria
p
oval
sampl
mix
infect
seen
state
malaria
endem
misidentif
malari
parasit
may
prolong
parasit
clearanc
time
lead
resist
antimalari
drug
sever
anaemia
p
vivax
p
oval
caus
relaps
p
malaria
sustain
low
rate
commun
decad
complic
malaria
epidemiolog
subsequ
control
thu
need
improv
qualiti
microscopi
rapid
diagnost
test
india
invas
salmonella
infect
huge
global
burden
worldwid
annual
estim
typhoid
fever
million
paratyphoid
fever
million
invas
nontyphoid
salmonella
diseas
int
million
morbid
mortal
high
especi
resourcelimit
set
compromis
host
invas
nontyphoid
salmonella
diseas
princip
salmonella
typhimurium
salmonella
enteritidi
routin
prospect
surveil
antimicrobi
resist
readili
avail
current
resist
chloramphenicol
ampicillin
cotrimoxazol
mdr
declin
howev
use
need
multipl
dose
longer
cours
therapi
week
risk
chloramphenicol
myelotox
higher
relaps
rate
fluorquinolon
resist
common
henc
unreli
therapi
third
gener
cephalosporin
oral
parenter
current
mainstay
safe
effect
howev
mic
creep
rare
full
resist
report
azithromycin
good
altern
oral
singl
daili
dose
excel
tissu
penetr
high
intracellular
concentr
almost
neglig
relaps
rate
resist
alreadi
report
combin
therapi
third
gener
cephalosporin
discuss
manag
int
diseas
yet
fulli
determin
due
lack
adequ
laboratori
clinic
data
third
gener
cephalosporin
least
week
convent
therapi
improv
public
health
hygien
wider
use
approv
typhoid
vaccin
design
new
vaccin
target
serovar
paratyphi
typhimurium
enteritidi
choleraesui
urgent
need
reduc
burden
new
approach
develop
live
attenu
multival
salmonella
vaccin
also
progress
high
preval
sever
diseas
children
two
year
age
present
avail
vaccin
use
children
need
conjug
vaccin
administ
infant
children
ciprofloxacinresist
shigella
sonnei
associ
travel
india
shigella
spp
major
pathogen
food
born
diseas
shigella
dysenteria
serotyp
caus
sever
diseas
outbreak
even
epidem
occasion
outbreak
antibioticresist
sonnei
report
industrialis
world
especi
among
children
outbreak
also
report
develop
countri
india
sever
outbreak
dysenteri
high
mortal
caus
multidrugresist
dysenteria
type
later
reemerg
fluoroquinolon
resist
caus
sever
dysenteri
outbreak
recent
foodborn
outbreak
due
sonnei
report
india
emerg
ciprofloxacinresist
sonnei
caus
outbreak
spread
among
intern
travel
caus
seriou
concern
antimicrobi
drug
resist
seriou
worldwid
issu
countri
poor
sanit
excess
use
antibiot
human
anim
sever
studi
show
emerg
ciprofloxacinresist
sonnei
india
view
ciprofloxacin
longer
recommend
empir
therapi
sonnei
infect
